Critically, upon binding to their respective ligands (PD-L1/PD-L2, MHC class II, and CD80/CD86) expressed on tumor or antigen-presenting cells, these receptors initiate potent immunosuppressive signaling cascades (14–16). The gene discussed is CD274; the disease is neoplasm.